Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay

Completed · Not applicable

Conditions studied: Hemophilia A

In brief

A novel immuno-assay is being evaluated for the measurement of Factor VIII. Current procedure measures a rate assay which is subject to much artefact. The hypothesis is that the new assay will give a reading of absolute quantities of FVIII which will provide a more suitable indicator of FVIII content for clotting factor manufacturers, physicians and patients.

Key facts

Study ID

NCT00839202

Run by

Children's Hospital Los Angeles

People needed

7

Starts

2006-09-01

Expected to finish

2009-02-01

Last updated by the study team

2017-02-01

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• adults with hemophilia A
• factor VIII less that 2%
• informed consent signed
• absence of an inhibitor

You may not qualify if…

• history of a high responding inhibitor anemia

Where it is running

• Department of Biochemistry University of Vermont — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.